Results:
Results are measured by successful resolution of symptoms, defined by at least a 50% decrease in severity of the presenting headache/Migraine, or by return to work/regular activity. Only 62 patients from the total pool, and 22 from the headache pool (2%) had unsuccessful treatment that required re-treatment in the clinic, hospital ED or inpatient admission. This represents a 98% rate of effective treatment in the clinic.
Conclusions:
We conclude that outpatient IV therapy of refractory headaches/Migraines is highly successful with an extremely low need for re-treatment, contributing to productivity in the workplace, at home and in personal life. This method of treating refractory Migraines is much more satisfactory than using currently available (and limited) pharmacologic agents given commonly in the ED.
___________
Reference:
Krusz, John Claude, PhD, MD; Belanger, Jeanne, RN; Cagle, Jane, LVN. “IV Treatment of Refractory Migraines in the Headache Clinic: High Success Rate.” Poster Abstract. 49th Annual Scientific Meeting of the American Headache Society. Chicago. June, 2007; in Headache, 47:752, May 2007.
© Teri Robert, 2007.
Last updated October 6, 2007.
